Biosimilars 2017
06.03.2017 16:19
This conference gives you a thorough update on the challenges when developing a biosimilar and also addresses the market access necessities.
Termindetails
Wann
21.06.2017 um 09:00 bis
22.06.2017 um 15:30
22.06.2017 um 15:30
Wo
Frankfurt/Offenbach
Kontakttelefon
+49 6221 500 680
Teilnehmer
This conference addresses the needs of managers in the pharmaceutical industry who work with biosimilars.
Those working in the following areas will particularly benefit from this event:
- Marketing authorisation
- Clinical and preclinical development
- CMC/quality and analytics
- Market access and business development
- Legal affairs/patent protection
Those working in the following areas will particularly benefit from this event:
- Marketing authorisation
- Clinical and preclinical development
- CMC/quality and analytics
- Market access and business development
- Legal affairs/patent protection
Do you work in biosimilars or intend to do so? Then you should not miss this conference with leading biosimilars experts. During the two conference days, you will receive a full update from development requirements, to marketing authorisation requirements through to reimbursement topics. I would be very pleased to welcome you on the 21st June at the conference! Dr Henriette Wolf-Klein Department Manager Pharma & Healthcare
- Substitution and interchangeability
- current status in Germany, the EU and the US
- Extrapolation of indications - remaining challenges
- SPC and patents - managing product protection life cycles
- Key considerations for combination products
- Analytical development and comparability exercises
